School of Pharmacy, Cedarville University, Cedarville, OH 45314, United States.
Curr Protein Pept Sci. 2021;22(2):121-133. doi: 10.2174/1389203721666200921153513.
In the current omics-age of research, major developments have been made in technologies that attempt to survey the entire repertoire of genes, transcripts, proteins, and metabolites present within a cell. While genomics has led to a dramatic increase in our understanding of such things as disease morphology and how organisms respond to medications, it is critical to obtain information at the proteome level since proteins carry out most of the functions within the cell. The primary tool for obtaining proteome-wide information on proteins within the cell is mass spectrometry (MS). While it has historically been associated with the protein identification, developments over the past couple of decades have made MS a robust technology for protein quantitation as well. Identifying quantitative changes in proteomes is complicated by its dynamic nature and the inability of any technique to guarantee complete coverage of every protein within a proteome sample. Fortunately, the combined development of sample preparation and MS methods have made it capable of quantitatively comparing many thousands of proteins obtained from cells and organisms.
在当前的组学研究时代,在试图检测细胞内存在的全部基因、转录本、蛋白质和代谢物的技术方面取得了重大进展。尽管基因组学极大地提高了我们对疾病形态以及生物体如何对药物做出反应等方面的理解,但获得蛋白质组水平的信息至关重要,因为蛋白质在细胞内执行着大部分功能。获得细胞内蛋白质的蛋白质组范围信息的主要工具是质谱(MS)。虽然它历来与蛋白质鉴定有关,但过去几十年的发展使 MS 成为蛋白质定量的强大技术。由于其动态性质以及任何技术都无法保证对蛋白质组样本中每个蛋白质的完全覆盖,因此鉴定蛋白质组中的定量变化很复杂。幸运的是,样品制备和 MS 方法的联合发展使其能够对从细胞和生物体中获得的数千种蛋白质进行定量比较。